FTRE
Fortrea Holdings Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.25B
P/E Ratio
—
EPS
$-4.81
Beta
1.91
52W High
$18.67
52W Low
$3.97
50-Day MA
$11.14
200-Day MA
$11.77
Dividend Yield
—
Profit Margin
-16.50%
Forward P/E
7.87
PEG Ratio
0.34
About Fortrea Holdings Inc.
Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry. The company is headquartered in Durham, North Carolina.
Fundamentals
| Revenue (TTM) | $2.71B |
| Gross Profit (TTM) | $510.90M |
| EBITDA | $69.90M |
| Operating Margin | 0.52% |
| Return on Equity | -64.50% |
| Return on Assets | -0.05% |
| Revenue/Share (TTM) | $29.42 |
| Book Value | $6.05 |
| Price-to-Book | 2.38 |
| Price-to-Sales (TTM) | 0.46 |
| EV/Revenue | 0.82 |
| EV/EBITDA | 92.35 |
| Quarterly Earnings Growth (YoY) | -57.40% |
| Quarterly Revenue Growth (YoY) | -2.30% |
| Shares Outstanding | $94.58M |
| Float | $93.90M |
| % Insiders | 0.82% |
| % Institutions | 109.99% |
Historical Volatility
HV 10-Day
29.31%
HV 20-Day
83.82%
HV 30-Day
75.29%
HV 60-Day
67.24%
HV Rank
29.4%
Volatility is currently contracting
Analyst Ratings
Consensus ($16.21 target)
5
Buy6
Hold1
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026